Related Experiment Video

Updated: Aug 14, 2026

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
05:52

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

[Infectious complications in the child undergoing hematopoietic stem cell transplantation]

F R Schuster1, H-J Laws

  • 1Hämatologisch/Onkologische Abteilung, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München. Friedhelm.Schuster@med.uni-muenchen.de

Klinische Padiatrie
|November 17, 2005
PubMed

Insights

Hematopoietic stem cell transplantation (HSCT) patients face infection risks influenced by immune system recovery. Understanding infection risks during early, intermediate, and late phases of immune reconstitution is crucial for patient outcomes.

Area of Science:

  • Immunology
  • Hematology
  • Pediatric Oncology

Context:

  • Hematopoietic stem cell transplantation (HSCT) is a critical treatment for various pediatric and adult diseases.
  • Infectious complications are a significant source of morbidity and mortality post-HSCT.
  • Immune system function, crucial for combating infections, is directly impacted by immunosuppressive therapy and immune reconstitution speed.

Purpose:

  • To delineate the infection risks across different phases of immune reconstitution following HSCT in pediatric patients.
  • To highlight variations in infection risks among children receiving conventional oncologic treatments versus those undergoing autologous or allogeneic HSCT.
  • To emphasize the long-term immune deficiency as a risk factor for severe infections post-HSCT.

Summary:

  • Infection risk post-HSCT is stratified by immune reconstitution phases: early, intermediate, and late.
  • Pediatric HSCT patients exhibit distinct infection profiles based on treatment type (oncologic, autologous, allogeneic).
  • Prolonged immune deficiency significantly elevates the risk of severe infections long after HSCT.

Impact:

  • Provides critical insights for optimizing infection prophylaxis and management strategies in pediatric HSCT recipients.
  • Informs clinical decision-making regarding the timing and intensity of immunosuppressive therapies.
  • Enhances understanding of long-term complications, guiding supportive care and follow-up protocols for improved survival rates.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...